Cytokinetics Inc
CYTK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001061983
In the last 90 days, Cytokinetics Inc insiders filed 0 open-market purchases and 16 sales; 482 institutions reported holding it in 13F filings for Q2 2026, worth $13.7B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Cytokinetics Inc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 250
- +42 vs. Q3 2021
- Shares held
- 91.4M
- +1.19M (+1.3%) vs. Q3 2021
- Total value
- $4.16B
- +$941.9M (+29.3%) vs. Q3 2021
- New holders
- 53
- 84 more added
- Sold out
- 11
- 79 more reduced
3 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CYTK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 482 | $13.7B |
| Q1 2026 | 441 | $9.63B |
| Q4 2025 | 431 | $8.87B |
| Q3 2025 | 381 | $7.75B |
| Q2 2025 | 312 | $4.55B |
| Q1 2025 | 356 | $5.48B |
| Q4 2024 | 347 | $6.18B |
| Q3 2024 | 348 | $7.20B |
| Q2 2024 | 344 | $7.34B |
| Q1 2024 | 390 | $8.26B |
| Q4 2023 | 347 | $9.54B |
| Q3 2023 | 251 | $3.22B |
| Q2 2023 | 253 | $3.55B |
| Q1 2023 | 263 | $3.83B |
| Q4 2022 | 278 | $4.88B |
| Q3 2022 | 276 | $5.08B |
| Q2 2022 | 263 | $4.16B |
| Q1 2022 | 240 | $3.52B |
| Q4 2021 | 250 | $4.16B |
| Q3 2021 | 211 | $3.22B |
| Q2 2021 | 191 | $1.50B |
| Q1 2021 | 193 | $1.74B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Cytokinetics Inc; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 237,807 | $10.8M | 0.01% | −272,180−53.4% | Reduced |
| UBS Group AG | 244,373 | $11.1M | 0.00% | +109,869+81.7% | Added |
| Federated Hermes, Inc. | 245,198 | $11.2M | 0.02% | +245,198 | New |
| Parametric Portfolio Associates LLC | 268,586 | $12.2M | 0.01% | +11,896+4.6% | Added |
| CM Management, LLC | 275,000 | $12.5M | 9.47% | 00.0% | Unchanged |
| Bank of America Corp | 294,733 | $13.4M | 0.00% | +63,094+27.2% | Added |
| Pinnacle Associates Ltd | 315,192 | $14.4M | 0.25% | −2,023−0.6% | Reduced |
| Integral Health Asset Management, LLC | 325,000 | $14.8M | 4.13% | 00.0% | Unchanged |
| Bain Capital Public Equity Management II, LLC | 341,272 | $15.6M | 0.57% | −310,341−47.6% | Reduced |
| Great Point Partners LLC | 350,000 | $16.0M | 3.57% | −41,429−10.6% | Reduced |
| Alliancebernstein L.P. | 356,929 | $16.3M | 0.01% | +106,047+42.3% | Added |
| American Century Companies Inc | 416,497 | $19.0M | 0.01% | +67,504+19.3% | Added |
| Sofinnova Investments, Inc. | 464,366 | $21.2M | 1.36% | +37,734+8.8% | Added |
| Candriam Luxembourg S.C.A. | 513,344 | $23.4M | 0.15% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 558,704 | $25.5M | 0.01% | −425,761−43.2% | Reduced |
| Ameriprise Financial Inc | 559,582 | $25.5M | 0.01% | +206,147+58.3% | Added |
| Opaleye Management Inc. | 580,000 | $26.4M | 5.61% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 584,666 | $26.6M | 0.01% | −26,867−4.4% | Reduced |
| Two Sigma Investments, LP | 588,741 | $26.8M | 0.07% | −89,833−13.2% | Reduced |
| Hood River Capital Management LLC | 619,664 | $28.2M | 0.85% | −3,992−0.6% | Reduced |
| Frontier Capital Management Co LLC | 660,815 | $30.1M | 0.24% | −94,623−12.5% | Reduced |
| Principal Financial Group Inc | 677,116 | $30.9M | 0.02% | +77,885+13.0% | Added |
| Cormorant Asset Management, LP | 700,000 | $31.9M | 1.90% | −300,000−30.0% | Reduced |
| Commodore Capital LP | 704,537 | $32.1M | 7.44% | −92,041−11.6% | Reduced |
| Invesco Ltd. | 759,669 | $34.6M | 0.01% | +332,610+77.9% | Added |
| Two Sigma Advisers, LP | 779,100 | $35.5M | 0.09% | −40,800−5.0% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 809,000 | $36.9M | 0.78% | −727,758−47.4% | Reduced |
| Lord, Abbett & Co. LLC | 833,068 | $38.0M | 0.09% | +833,068 | New |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 840,601 | $38.3M | 0.13% | +18,854+2.3% | Added |
| Morgan Stanley | 871,662 | $39.7M | 0.00% | +30,738+3.7% | Added |
| Bank of New York Mellon Corp | 881,170 | $40.2M | 0.01% | +88,629+11.2% | Added |
| Point72 Asset Management, L.P. | 885,454 | $40.4M | 0.18% | −123,846−12.3% | Reduced |
| Artal Group S.A. | 1,000,000 | $45.6M | 1.34% | −300,000−23.1% | Reduced |
| Northern Trust Corp | 1,009,345 | $46.0M | 0.01% | −595−0.1% | Reduced |
| Franklin Resources Inc | 1,039,073 | $47.4M | 0.02% | +39,026+3.9% | Added |
| Wellington Management Group LLP | 1,123,072 | $51.2M | 0.01% | +71,216+6.8% | Added |
| Logos Global Management LP | 1,325,000 | $60.4M | 6.23% | +325,000+32.5% | Added |
| Geode Capital Management, LLC | 1,428,622 | $65.1M | 0.01% | +30,574+2.2% | Added |
| Boxer Capital, LLC | 2,100,000 | $95.7M | 3.81% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 2,170,342 | $98.9M | 0.56% | −562,433−20.6% | Reduced |
| Wasatch Advisors Inc | 2,183,250 | $99.5M | 0.41% | −464,787−17.6% | Reduced |
| Driehaus Capital Management LLC | 2,327,112 | $106.1M | 1.08% | −562,414−19.5% | Reduced |
| PFM Health Sciences, LP | 2,465,016 | $112.4M | 3.92% | −694,685−22.0% | Reduced |
| RTW Investments, LP | 2,561,182 | $116.7M | 1.70% | +561,182+28.1% | Added |
| Pictet Asset Management SA | 2,604,797 | $118.7M | 0.12% | +214,005+9.0% | Added |
| Polar Capital Holdings Plc | 3,671,969 | $167.4M | 0.87% | +657,087+21.8% | Added |
| State Street Corp | 3,985,227 | $181.6M | 0.01% | −325,061−7.5% | Reduced |
| Vanguard Group Inc | 6,989,719 | $318.6M | 0.01% | +1,675,188+31.5% | Added |
| FMR LLC | 12,540,549 | $571.6M | 0.04% | +55,542+0.4% | Added |
| BlackRock Inc. | 12,950,964 | $590.3M | 0.02% | −311,983−2.4% | Reduced |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −338,367−100.0% | Sold out |
| Keybank National Association | 0 | $0 | 0.00% | −75,692−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −38,942−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −13,990−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −12,374−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −7,152−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,910−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −193−100.0% | Sold out |
| Glen Eagle Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |
| First Mercantile Trust Co | – | – | – | – | Not filed |
| Berman Capital Advisors, LLC | – | – | – | – | Not filed |